Full Text
PMH45 COST-UTILITY OF AGOMELATINE, VENLAFAXINE AND PLACEBO IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER (MDD) IN FINLAND-ECONOMIC MODELLING STUDY USING REPRESENTATIVE POPULATION DATA

Abstract

Authors

EJ Soini TA Hallinen

Back to Volume 12, Issue 7
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×